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Summary 
Staphylococcus aureus strain D4508 is a toxic shock syndrome toxin 1-negative clinical isolate from 
a nonmenstrual case of toxic shock syndrome (TSS). In the present study, we have purified and 
characterized a new exotoxin from the extracellular products of this strain. This toxin was found 
to have a molecular mass of 25.14  kD by mass spectrometry and an isoelectric point of 5.65 
by isoelectric focusing. We have also cloned and sequenced its corresponding genomic determinant. 
The DNA sequence encoding the mature protein was found to be 654 base pairs and is predicted 
to encode a polypeptide of 218 amino acids. The deduced protein contains an NH2-terminal 
sequence identical to that of the native protein.  The calculated molecular weight (25.21  kD) 
of the recombinant mature protein is also consistent with that of the native molecules. When 
injected intravenously into rabbits, both the native and recombinant toxins induce an acute TSS- 
like illness characterized by high fever, hypotension, diarrhea, shock, and in some cases death, 
with classical histological findings of TSS. Furthermore, the activity of the toxin is specifically 
enhanced by low quantities of endotoxins. The toxicity can be blocked by rabbit immunoglobulin 
G antibody specific for the toxin. Western blotting and DNA sequencing data confirm that the 
protein is a unique staphylococcal exotoxin, yet shares significant sequence homology with known 
staphylococcal enterotoxins, especially the SEA, SED,  and SEE toxins. We conclude therefore 
that this 25-kD protein belongs to the staphylococcal enterotoxin gene family that is capable 
of inducing a TSS-like  illness  in rabbits. 
T 
he staphylococcal enterotoxins are extracellular products 
secreted by a variety of Staphylococcus aureus  strains (1). 
In addition to being responsible for food poisoning in humans, 
increasing evidence suggests  that  enterotoxins  contribute 
significantly to staphylococcus-associated toxic shock syndrome 
(TSS) 1, an acute illness characterized by fever, hypotension, 
dysfunction of multiple organ systems, and desquamation of 
the skin during recovery (2-5). There are five known members 
of the staphylococcal enterotoxin family, designated as staph- 
ylococcal enterotoxins A-E (SEA-E). Each member has its 
unique biochemical and  serological properties,  but  shares 
significant homology in sequence, structure, and biological 
functions with other family members (1, 6). Staphylococcal 
enterotoxins are also characterized as "superantigens" with 
all members activating large numbers of T cells bearing par- 
ticular TCR V~ elements (7-9). As a result of T cell activa- 
1 Abbreviations used in this  paper: FPLC, fast protein  liquid chromatography; 
LB, Luria-Bertani  medium;  pI, isoelectric  point; SEA, SEB, SEC1, SEE, 
staphylococcal  enterotoxins  A, B, C1, D, and E, respectively;  TSS, toxic 
shock syndrome;  TSST-1, TSS toxin 1. 
tion,  T  cell proliferation and cytokine expression are pro- 
foundly elevated. The superantigen properties of these toxins 
have led to the concept of their use as potential therapeutic 
agents in the treatment of carcinoma and autoimmune dis- 
orders (10, 11). 
In a previous study, we reported the identification of a new 
exotoxin from staphylococcal strain D4508,  a TSS toxin 1 
(TSST-1)-negative clinical isolate from a patient with non- 
menstrual TSS (12). This toxin, called BR4, was shown to 
be related to but different from other known enterotoxins 
and TSST-1. When injected into rabbits, partially purified 
BR4 induced a TSS-like  disease and death in the animals. 
The toxicity was completely blocked by polyclonal antibodies 
against the BR4 material. However, since the preparation was 
only partially purified from the staphylococcal extraceUular 
products, the issue as to the true nature of the BR4 protein, 
its properties, and its correlation with other known staphy- 
lococcal toxins, was not completely resolved (4,  12). 
In this report, we purified the BR4 protein from the ex- 
traceUular products  of strain D4508  to  homogeneity and 
studied its biochemical and biological properties. This toxin 
was found to have a molecular mass of 25 kD, an isoelectric 
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like illness in rabbits. To further study the structural charac- 
teristics of this 25-kD protein and its relationship with other 
staphylococcal toxins, the toxin was cloned and its DNA se- 
quence analyzed.  By virtue of shared biological properties 
and considerable sequence homology at both the nucleic acid 
and protein levels with staphylococcal enterotoxins A through 
E, this toxin is suggested to be a member of the staphylococcal 
enterotoxin gene family and  has been provisionally named 
SEH. 
Materials  and Methods 
Strains and Vector.  S. aureus strain D4508 was  obtained from 
the Centers for Disease Control (Atlanta, GA) (12). Escherichia coli 
strains Y1088, Y1089, Y1090, and K-12 XL1-Blue were purchased 
from Stratagene (La Jolla, CA). E. coli INVccF' and BL21(DE3)pLysS 
were obtained from Invitrogen (San Diego,  CA)  and Novagen 
(Madison, WI), respectively. The bacteriophage Xgt11 vector was 
purchased from Stratagene. Plasmid pHSG399 was a gift from the 
Japanese  Cancer Research  Resources bank  (Tokyo, Japan)  (13). 
Plasmid pCRII and pET-17b were purchased from Invitrogen and 
Novagen, respectively. S. aureus cultures were grown in chemically 
defined medium (12). E. coli strains  were grown in Luria Bertani 
medium (LB) or NZCYM medium as required (14). 
Enzymes and Chemicals.  Restriction and modifying enzymes 
were purchased from Stratagene and Promega (Madison, WI) or 
Boehringer Mannheim (Indianapolis,  IN) and used according to 
the recommendations of the manufacturers. Sequetide Nucleotide 
Premix was  purchased  from DuPont  NEN  Research  Products 
(Boston, MA). Reagents for syntheses of oligonucleotide primers 
were purchased from Pharmacia P-L Biochemicals (Milwaukee, WI). 
Antibiotics and general reagents were purchased from Sigma Chem- 
ical Co.  (St.  Louis,  MO). 
Monitoring the Purification ofSEH.  A partially purified BR4 prep- 
aration was kindly provided by W. W. Hall (The Rockefeller Univer- 
sity, New York) (12). BR4,  present in this sample  and electroe- 
luted from preparative SDS-PAGE gel s/ices, was  then used as a 
standard to isolate additional SEH for antibody preparation. Both 
the electroeluted SEH and affinity-purified anti-SEH F(ab')z anti- 
body were then used to monitor chromatographic purification of 
SEH. 
Gel Electrophoretic Analysis.  All analysis for polypeptides was 
carried out using 12.5% SDS-PAGE gels (15). Silver staining was 
performed by using a Gelcode System (Color Silver Stain Kit; Pierce, 
Rockford, IL). Preparative SDS-PAGE was performed on a vertical 
gel (16  x  10  x  0.5 cm) in a SE 400 system using a 2-well comb 
(Hoefer Scientific  Instruments,  San Francisco,  CA).  All analysis 
for DNA was performed with 0.8% agarose gels according to stan- 
dard procedures (14). 
Preparation of Anti-SEH F(ab')2 Fragments.  Anti-SEH sera were 
prepared by immunizing rabbits  with  gel slices excised from a 
preparative SDS-PAGE (16). Primary and booster injections con- 
sisted  of '~50-70 #g of protein.  Rabbits were boosted twice at 
monthly intervals and bled 10 d thereafter. The titer was moni- 
tored by Western blotting. 
Rabbit anti-SEH IgG, isolated from hyperimmune serum using 
immobilized protein A-Sepharose column (Pharmacia Fine Chem- 
icals, Piscataway,  NJ), was  then affinity purified (17) and pepsin 
digested (Pierce)  as outlined by the company. The purity of the 
F(ab')z was  evaluated  by SDS-PAGE. 
lmmunoblotting Analyses.  Phage plaques developed on LB plates 
or polypeptides separated on SDS-PAGE were transferred to nitrocel- 
lulose membranes (Schleicher & SchueU, Inc., Keene, NH) according 
to the procedure of Towbin et al. (18). After overnight blocking, 
the first antibody was applied  and allowed  to react for 1 h with 
shaking at room temperature.  Alkaline phosphatase-conjugated sec- 
ondary antibody (1:1,000) (Sigma Chemical Co.) was added and 
reactive bands were visualized as described by Blake et al. (19). SEA-E 
and TSST-1 toxins were obtained from Toxin Technology, Ltd. 
(Madison, WI).  Mouse monoclonal IgG specific for SEA-E and 
TSST-1 were obtained from IGEN Inc. (Rockville, MD) and diluted 
1:500 in blocking buffer before use. 
Purification of SEH.  Extracellular products were isolated from 
strain D4508, precipitated stepwise with 55 and 75% saturation 
of ammonium sulfate (4~  overnight), and partially purified with 
DEAE-cellulose (Sigma Chemical Co.) columns (6  x  2.5 cm) as 
previously described (12). The DEAE fractions containing partially 
purified SEH were concentrated further with a Diaflo concentrator 
fitted with a PM10 filter (Amicon Corp., Danvers, MA), dialyzed 
against  25 mM Tris-HC1  (pH 8.1), and applied  to a fast-protein 
liquid chromatography (FPLC) column (Mono Q HR5/5; Phar- 
macia Fine Chemicals), equilibrated in the same buffer. The column 
was washed and protein eluted with a linear gradient from 0 to 
500 mM NaC1. Fractions of 1 ml each were collected and analyzed 
by SDS-PAGE and Western blot. Fractions containing SEH were 
dialyzed against  50 mM ammonium bicarbonate, and lyophilized. 
After resuspension in 500 #1 of this same buffer, the sample was 
applied to an FPLC Superose 12 column (Pharmacia  Fine Chem- 
icals) and fractions (1 ml each) were analyzed as described  above 
for SEH. The purity of the protein was evaluated by SDS-PAGE 
followed by Coomassie blue and silver staining.  The apparent mo- 
lecular size of SEH was determined by SDS-PAGE with Rainbow 
Protein Molecular Markers (Amersham, Arlington Heights, IL). 
Protein concentration was determined by a microtiter BCA assay 
(Pierce).  The purified SEH was  stored at  -20~ 
IEE  IEF was performed with a Rotorfor cell (Bio-Rad Labora- 
tories, Richmond, CA). Briefly, "~100 #g of the purified SEH pro- 
tein was dialyzed against  5 mM NaC1 and concentrated to 2 ml 
with a Diaflo concentrator fitted with a PM10 filter. This was added 
to 52 ml of 2% Bio-Iyte ampholyte, pH 3-10 (Bio-Rad Laborato- 
ries) containing 20% glycerol, and applied to the Rotofor cell. Ini- 
tial focusing was carried out at 12 W  constant power for 4 h at 
4~  The pH values and the absorbance at 280 nm of each 2.5-ml 
fraction were determined. Aliquots of each fraction were analyzed 
on SDS-PAGE and Western blot. Fractions 7-9, having a pH range 
of 5.55 to 6.00, and containing the majority of SEH, were pooled, 
diluted  up  to  52  ml  of double distilled  HzO  containing 20% 
glycerol, and refocused for an additional 4 h. 
Mass Spectrometry.  The matrix-assisted  laser desorption mass 
spectrometric analysis was performed at The Rockefeller Univer- 
sity (Laboratory of Mass Spectrometry and Gas Phase Ion Chem- 
istry) on a time-of-flight mass spectrometer (20). 
NHe-terminat Sequence.  The purified SEH was subjected to au- 
tomated Edman degradation on a sequenator (model 470 A; Ap- 
plied Biosystems,  Inc., Foster City, CA). All analytic  procedures 
were performed by the Protein Sequence/Biopolymer Facility of 
The Rockefeller University. 
Genomic DNA Cloning Procedures.  Chromosomal DNA was iso- 
lated from strain  D4508 as described  (21) and a genomic DNA 
library was constructed in Xgtll (14). The unamplified  library was 
plated with E. coli Y1090 cells and screened using immunoblots 
reacted with the affinity-purified  anti-SEH F(ab')z which was ab- 
sorbed with E. coti/phage  lysate (Promega) before use. 
Subcloning Procedure.  The method of Struhl (22) was used to 
subclone DNA fragments from agarose  gels. To clone the insert 
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XL1-Blue and selected on LB agar plates containing 30/xg/ml chlor- 
amphenicol. For TA cloning using vector pCR II, ligation prod- 
ucts were transformed into strain INVc~F' and selected by blue/white 
color on ampicillin-resistant  LB plates containing X-Gal (1 mg/plate) 
(Boehringer Mannheim). 
Oligonucleotide  Synthesis and PCR Procedures.  The oligonucleo- 
tide primers were synthesized on a DNA synthesizer (model 380B; 
Pharmacia Fine Chemicals). The PCR primers used for direct TA 
doning were K3 (GTAATAATGCTAAAAACGAAAATAA) along 
with  two primers of gt11  sequences.  The PCR primers used to 
clone the complete coding region for the mature SEH were K4 
(CCCTCGAGTTATACTTTTTTCTTAGTATATAG)  and  R3 
(TCAAGCTTGGAAGATTTACACGATAAAAGT). 25  cycles of 
amplification (1 rain at 94~  2 rain at 50~  and I rain at 72~ 
were performed in a thermal cycler (Perkin-Elmer Cetus Instru- 
ments,  Norwalk,  CT). 
DNA Sequence  Analysis.  The recombinants pSEH1 and pSEH2 
were used to determine the seh sequence.  The DNA sequence was 
obtained using the method of Sanger et al.  (23) with Sequenase 
2.0 (United States  Biochemical Corp.,  Cleveland, OH). The seh 
sequence was submitted to EMBL/GenBank/DDBJ and has been 
assigned the accession number Ul1702. Hydropathy analysis of the 
deduced amino acid of SEH was performed using the DNA strider TM 
computer program employing the method of Hopp and Woods 
(24).  Predictions of signal sequence and its cleavage  sites as well 
as  Shine-Dalgarno  site  were  performed  as  described  previously 
(25-27).  The deduced amino acid  sequence of SEH was used to 
search the translated GenBank database for greatest homology using 
the program Fasta (28).  The alignment of SEH with related exo- 
toxins was created using the Pileup program (GCG, Madison, WI). 
Expression of SEH in T7 Promoter System.  PCR was used to 
amplify seh from chromosomal DNA of strain D4508.  The PCR 
product was then cloned into pET-17b creating pKR100 and trans- 
formed into strain BL21 (DE3) cells. Transformants were selected 
on carbenicillin plates. IPTG (Isopropyhhio-/3-D-galactoside)-induced 
cell lysates of positive clones were then analyzed for the expression 
of SEH by SDS-PAGE and Western blotting. A cell lysate containing 
the pET vector alone was used as a control. 
Purification of the rSEH.  BL21(DE3)(pLysS)(pKY100)  cells were 
grown in LB broth  at 32~  to  an ODr00 of 0.6  and  T7 RNA 
polymerase expression was then induced by adding IPTG to a final 
concentration of 0.4 raM. After 30 rain incubation, rifampicin (200 
/xg/ml) was added to the culture. 2 h later, ceils were collected and 
lysed by freeze-thaw and briefly by sonication in the presence of 
0.1% Triton X-100. Cell suspension was then centrifuged and su- 
pernatant was collected and used for further purification as described 
above for the purification  of wild-type toxin. 
Biologic Analysis of SEH in Rabbits.  The toxic effect of the na- 
tive or rSEH was evaluated in rabbits (29).  New Zealand White 
rabbits >1 yr old were obtained from Hazleton Dutchland Labs, 
Inc. (Denver, PA). Purified SEH, suspended in pyrogen-free saline, 
was applied to Endotoxin Removing Gel (Pierce) before use. The 
SEH was delivered intravenously into the rabbits through the mar- 
ginal ear vein at doses ranging from 40 to 150 #g/kg. Rabbits were 
monitored closely for clinical  symptoms and  death  for 5  d.  To 
evaluate the pyrogenic effects,  rectal temperatures were measured 
and the course of  temperature changes (temperature of  injected rabbit 
minus that of normal control) was monitored at appropriate time 
points. Age- and sex-matched rabbits receiving isotonic saline served 
as normal controls. Student's t-test was used for statistical analyses 
and values  of p  <0.05  were considered significant. 
To study the biological effects of SEH in the presence of sublethal 
doses of endotoxin, a method used for studying TSST-1 was adapted 
(30). Briefly, a dose of 5 #g/kg LPS (from E. coli; Difco Laborato- 
ries, Inc., Detroit, MI) was injected intravenously into rabbits 4 h 
after SEH injection. Rabbits receiving 5/zg/kg LPS alone served 
as the controls. 
For protection studies,  SEFt was mixed with anti-SEH IgG at 
a  1.5:1 molar ratio,  incubated at 37~  for 2 h,  and centrifuged 
at  12,000  g  for 5 min.  The supernatant  fluid  was then used for 
i.v. injection.  The mixture of SEH and normal rabbit IgG, processed 
the same way, was used as the control. The rabbits were observed 
over a 72-h  period for clinical  signs of illness  and death. 
Histopathologic Studies.  Necropsies were performed on selected 
animals that died after injection of SEH. Tissues were fixed in 10% 
neutral buffered formalin, paraffin embedded, sectioned at 8-10/~m, 
stained with hematoxylin and eosin,  and examined via light mi- 
croscopy. Photomicrographs were taken at magnifications of 10 and 
25. All procedures were performed in the Laboratory Animal Re- 
search  Center  at The Rockefeller University. 
Results 
Purification  of SEH Protein.  SEH  could be concentrated 
from the total extracellular products of strain D4508 by am- 
monium sulfate precipitation of between 55 and 75%  satu- 
ration.  The SEH protein in this concentrate could be eluted 
with 100 mM NaC1 from a column of DEAE cellulose. Fur- 
ther purification on a MonoQ ion exchange and a Superose 
12 molecular sieve resulted in a single homogenous  protein 
migrating just below 30 kD on a SDS-PAGE gel (Fig. 1, a-c). 
A similar migration pattern was seen under reducing and non- 
reducing  conditions. 
BiochemicalProperties.  The apparent molecular mass of SEH 
could be readily distinguished from that of other staphylococcal 
exotoxins  (Fig.  2 A).  Analysis of the purified SEH by laser 
desorption mass spectrometry revealed a monomer of 25.145 
kD. Isoelectric focusing of purified SEH indicated of pI value 
of 5.65.  NHz-terminal  amino  acid sequence analysis of the 
purified SEH revealed a single amino acid at all 26 positions 
with the following  sequence:  E  D  L  H  D  K  S E  L  T  D  L 
A L A  N  A  Y  G  Q  Y  N  H  P F I. The result further verified 
the  homogeneity  of the  preparation. 
Immunological  Properties.  As shown in Fig. 2 B, anti-SEH 
F(ab')2 antibody did not  show any detectable reactivity with 
SEA, B, C, D, E or TSST-1 (lanes b-g). Furthermore, mAbs 
specific for enterotoxins  A,  B,  C,  and  TSST-1  showed  no 
Figure  1.  SDS-PAGE  and Western 
blot analysis  of the purified SEH pro- 
tein after FPLC-Superose  chromatog- 
raphy.  (Lane a)  Gel  stained with 
Coomassie blue. (Lane b) A positive 
image of a photographed silver  stained 
gel; after silver  stain, a negative  image 
is seen in the position of SEH, indi- 
cating that the protein does not bind 
to silver. (Lane c) A Western blot of 
SEH reacted with  rabbit  anti-SEH 
IgG. The mass of carbonic anhydrase 
(30 kD) molecular weight standard is 
indicated. 
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staphylococcal  toxins. (A) SDS-PAGE  stained with Coomassie  blue: lanes 
a-g are SEH, A, B, C, D, E, and TSST-1, respectively.  (B) Western blot 
of toxins SEH, A, B, C, D, E, and TSST-1 (lanes  a-g, respectively)  reacted 
with rabbit anti-SEH IgG. (C) SEH toxin, separated on a toothless gel, 
was transferred to nitrocellulose and reacted with rabbit anti-SEH IgG 
(lane a), mouse  mAb specific  for SEA, B, C, TSST-1, SEE, and SED (lanes 
b-g), respectively. 
cross-reactivity with  SEH (Fig.  2  C,  lanes  b-e).  However, 
mAbs to SED and SEE did exhibit binding to SEH (Fig.  2, 
lanes f  and g). 
Cloning and ExFression of  the Gene Encoding SEll.  Genetic 
determinants coding for the mature SEH were isolated from 
a genomic library of strain D4508 using antibodies specific 
for wild-type  SEH.  Of 3  x  106 independent  gt11  phage 
clones  screened,  one positive clone was isolated and called 
gSEH.1. Immunoblot analysis  of the crude phage lysates of 
this  clone showed that  it  encoded  a  25-kD  protein  corre- 
sponding in size and antibody reactivity to the wild-type SEH 
(Fig.  3, lanes a and c).  This protein is not present in phage 
lysates prepared from the vector of),gt11 alone (Fig. 3, lane b). 
The Structure  of the seh  Gene.  The genomic library was 
constructed using the EcoRI cloning sites  of Xgt11.  How- 
ever, digestion of gSEH.1 phage DNA with EcoRI revealed 
that  one EcoRI site had been lost during  the cloning pro- 
cess. Accordingly, SacI, which cleaves Xgt11 1 kb away from 
the cloning  site,  was used in subcloning procedures,  A  1.7 
kb  SacI-EcoRI  fragment  was  subcloned  into  plasmid 
pHSG399, and the resulting plasmid was named pSEH1. DNA 
sequencing of pSEH1 indicated the 0.7-kb insert contained 
nearly the entire structural gene for SEH, except for a small 
portion  at  the  5'  end (Fig.  4 A). 
To obtain the 5' end ofseh,  a HpaI-EcoRI fragment from 
pSEH1 was used as a probe to screen the original  )~gtll  li- 
brary. 21 positive phage clones were isolated. PCR was used 
to amplify phage DNA  from each clone using primers  of 
both  K3  and  Xgt11  sequence.  PCR  products  from  am- 
plification  of positive clones were subcloned into the pCR 
II vector. One recombinant plasmid, pSEH2, contained a 1.4- 
kb insert. DNA sequencing ofpSEH2 revealed the complete 
5' end of seh.  A  restriction  map  of the complete seh  gene 
is  shown in  Fig.  4 A. 
The complete nucleotide sequence ofseh and its predicted 
amino acid sequence are shown in Fig. 5. The seh gene con- 
tains  a long open reading frame of 726 nucleotides starting 
from the initiation codon ATG at nudeotide positions 208-210 
and  ending  at  the  termination  codon  TAA  at  positions 
931-933. This open reading frame predicts a protein of 241 
amino acids in length.  The signal peptide is 24 amino acids 
in length, consisting of 21 nonpolar hydrophobic and 3 basic 
amino acids,  and shares  significant  similarities  with known 
signal peptide sequences (25). The hydropathy profile of the 
deduced amino acid sequence revealed the hydrophilic nature 
of the protein and also indicated the presence of a hydrophobic 
NH2 terminus consistent with a signal sequence (Fig.  4 B). 
The proposed processing  site for the mature protein  is lo- 
cated before the glutamic  acid encoded at  nucleotide posi- 
tion 280 (Fig.  5). An NH2-terminal amino acid sequence ob- 
tained from purified SEH matched the amino acid sequence 
deduced from the seh nucleotide sequence beginning at posi- 
tion 280 (Fig. 5). This suggests that the first 24 amino acids 
of SEH are a signal sequence which is removed to produce 
a mature protein  of 25.21 kD,  and is consistent with  that 
obtained by mass spectrometry of purified SEH (25.145 kD). 
Proximal  to  the 5'  end of the open  reading  frame is  a se- 
quence of GAGGAG, which resembles the consensus Shine- 
Delgarno  ribosome binding  site (27). 
Western  blot  analysis  of crude  cell  lysate  from  E.  coli 
BL21(DE3)(pLYS)(pSEH1),  revealed a single protein band with 
identical molecular weight and immunogenicity  to the na- 
tive SEH (Fig.  6).  Comparison of the amino acid composi- 
tion  of SEH with  those of other  staphylococcal toxins re- 
Figure 3.  Western  blotting of native 
and  recombinant SEH. (Lane a)  SEH 
purified from  8. aureus  strain D4508; (lane 
b) E. coli strain Y1089 phage lysate con- 
taining Xgt11; and (lane c) E. coli strain 
Y1089 phage  lysate  containing ),gtll with 
an seh insert (gSEH.1). Proteins trans- 
ferred to nitrocellulose  were  reacted  with 
antibody specific for wild-type SEH. 
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Figure 4.  (A) Schematic repre- 
sentations and a restriction map of 
lambda clones  encoding portions of 
SEH. Two phage DNA  clones, 
gSEH.1, and  gSEH.2, encoding 
different regions ofseh, are shown. 
To unique restriction enzyme  cleav- 
age sites of these clones are also in- 
dicated. (Dark solid box) The SEH 
open reading frame. (Striped box) 
The signal sequence. (Arrow) The 
orientation of the seh reading frame. 
(B) Hydropathy  profile  of the SEH 
amino acid sequence. The hydrop- 
athy plot was obtained using the 
DNA Strider  TM computer program 
employing  the method  of  Hopp and 
Woods (24). The numbers on the 
horizontal axes indicate the posi- 
tions of  amino acid  residues. (Arrow) 
The NHz-terminal end of SEH. 
vealed significant similarities,  particularly with those of the 
enterotoxin  family (1). 
Sequence Homology  of SEH with Known Proteins.  Using 
the deduced amino  acid sequences of the proposed mature 
SEH, sequence homology with other known proteins was 
examined using the translated GenBank database. The pro- 
teins with the highest similarity scores of SEH were within 
the staphylococcal enterotoxin family, including SEA through 
SEE and the Streptococcuspyogenes pyrogenic exotoxins A and 
C. SEH exhibited 38% amino acid identity with SEE, 37% 
with SEA, 37% with SED, 33% with SEB, and 27% with 
SEC. Thus, SEH appears to belong to the staphylococcal en- 
terotoxin family and is most closely related to the enterotoxins 
SEA, SED, and SEE (Fig.  7). Furthermore,  if conservation 
of the chemical characteristics  of amino acids is taken into 
account, an even closer relationship is observed between SEH 
and these enterotoxins. 
Lethal Toxicity of Wild-type SEll in Rabbits.  The toxic effect 
of SEH was evaluated in rabbits given a single i.v. dose varying 
from 40 to 150/~g/kg.  All rabbits receiving 150/zg/kg  of 
the purified  protein  developed acute  symptoms that  were 
generally characterized by high fever,  hyperemia,  lethargy, 
conjunctival suffusion, and diarrhea (Table 1). Two of three 
receiving this dose succumbed to lethal toxic shock, one within 
24 h  and the other within 48 h.  The third rabbit suffered 
severe shock but recovered in 72 h. Rabbits given either 40, 
60, or 80 #g/kg of SEH showed acute illness with high fever 
and hyperemia, with two of the three having diarrhea.  All 
rabbits receiving these doses recovered after 48-72 h (Table 1). 
High fever was a consistent and significant feature of the 
illness  in all animals  receiving SEH.  The first  sign of fever 
occurred as early as I  h after the injection, and temperature 
increased rapidly to a mean value of 3.0~  above normal (p 
<0.05) within 4 h (Fig.  8). The maximum increase of 3.5~ 
was observed between 18 and 24 h.  Up to 36 h after injec- 
tion,  the temperature remained elevated above control and 
there was no significant difference in the kinetics of the fever 
induced by any given dose of the SEH. The temperature of 
the rabbits receiving 40-80/zg/kg decreased rapidly between 
36 and 48 h. Only one rabbit receiving 150/zg/kg was still 
alive at 48 h and its temperature remained high (Fig. 8). The 
temperature changes were significantly different between the 
two dosage groups at 48 h  ~  <0.05). 
The ability of SEH to induce a TSS-like illness in rabbits 
was confirmed by protection studies. When SEH was allowed 
to react with its specific antibody before injection, the tox- 
icity of the protein was inhibited.  All rabbits challenged in 
this way were protected from symptoms, including fever, al- 
though a small elevation of temperature was observed in these 
rabbits in the first few hours after injection  (sotid squares 
in Fig.  8). 
Histopathological examination of tissue samples from two 
rabbits injected with  150/zg/kg  of purified SEH revealed 
marked pyloric muscular hypertrophy, multisystemic visceral 
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ATTAAACTAT 
70 
TTAATATTGG 
130 
ATTCATAAAT 
190 
TAATGAAATA 
240 
TCG  TTT  TTA 
S  F  L 
290 
GAT  TTA  CAC 
D  L  H 
20  30  40  50  60 
CATTTCCATT  CTAACTACTA  TAGC~C~A  TATCTA~  TATAAATCTT 
80  90  100  Ii0  120 
TTT~TAT~  ATATTCCATT  TCTAGAAACC  TATATTTTAT  GTTTGTAT~ 
140  150  160  ]70  180 
TGTTCGAAAT  TTATATA~A  AAAGT~TTT  TTQTTCTTTT  AT~GT 
200  210  220  230 
TAT~G~G~G  TTTTAAAA~  A~  ~TAAAATTAAAATA  TTATTT 
RBS  M  ~  ~  K  I  K  I  L  F 
250  260  270  280 
GCA  ~A  TTA  C~  TCA  TTC  ACA  TCA  TAT  GCG  AAA  GCA  G~ 
ADLLSFTSYAKA~ 
300  310  320  330 
GAT  AAA  AGT  GAG  TTA  ACA  GAT  ~A  GCT  ~A  GCT  ~T  GCA 
DKSELTDLALANA 
340  350  360  370 
TAT  GOT  CAA  TAT  AAT  CAC  CCA  TTC  ATT  AAA  GAA  AAT  ATA  AAC  AGT  GAT 
Y  G  Q  Y  N  H  P  F  I  K  E  N  I  K  S  D 
380  390  400  410  420 
GAA  ATA  AGT  GGA  GAA  AAA  GAT  TTA  ATA  TTT  AGA  AAT  CAA  GGT  GAT  AGT 
E  I  S  G  E  K  D  L  I  F  R  N  Q  G  D  S 
430  440  450  460  470 
GGC  AAT  GAT  TTG  AGA  GTA  AAG  TTT  GCA  ACT  GCT  GAT  TTA  GCT  CAG  AAG 
G  N  D  L  R  V  K  F  A  T  A  D  L  A  Q  K 
480  490  500  510  520 
TTT  AAA  AAT  AAA  AAT  GTA  GAT  ATA  TAT  GGG  GCA  TCT  TTT  TAT  TAT  AAG 
F  K  N  K  N  V  D  I  Y  G  A  S  F  Y  Y  K 
530  540  550  560  570 
TGT  GAA  AAA  ATA  AGT  GAA  AAT  ATT  TCT  GAA  TGT  CTA  TAT  GGA  GGT  ACA 
C  E  K  I  S  E  N  I  S  E  C  L  Y  G  G  T 
580  590  600  610 
ACA  CTA  AAT  AGT  GAA  AAA  TTG  GCA  CAG  GAA  AGG  GTG  ATT  GGT  GCT  AAT 
T  L  N  S  E  K  L  A  Q  E  R  V  I  G  A  N 
620  630  640  650  660 
GTT  TGG  GTA  GAT  GGT  ATT  CAA  AAA  GAA  ACA  GAA  TTA  ATA  CGA  ACA  AAT 
V  W  V  D  G  I  Q  K  E  T  E  L  I  R  T  N 
670 
AAG  AAA  AAT 
K  K  N 
720 
TTG  TCC  GAT 
L  S  D 
770 
GGT  CTA  ATT  GAA  TTT 
G  L  I  E  F 
820 
ATT  TAT  QAT  TTA  AAA 
I  Y  D  L  K 
860  870 
GAA  GAC  AAT  AAA  ACT 
E  D  N  K  T 
910  920 
AAT  CTA  TAT  ACT  AAG 
N  L  Y  T  K 
680  690  700  710 
G~  ACA  TTG  C~  G~  TTA  GAT  ATA  ~G  ATC  AGA  AAA  ATA 
V  T  L  Q  E  L  D  I  K  I  R  K  I 
730  740  750  760 
AAATATAAAA~  TATTATAAAGACAGCG~  ATAAGTAAA 
KYKIYYKDSEISK 
780  790  800  810 
GAT  ATG  AAA  ACT  CCT  AGA  GAT  TAC  TCA  TTC  GAC 
DMKTPRDYSFD 
830  840  850 
GGA  G~  ~T  GAC  TAT  GAG  ATA  GAT  AAA  A~  TAT 
GENDYEIDKIY 
880  890  900 
TTA  AAA  TCT  GAT  GAT  ATA  AGT  CAT  ATT  GAT  GTA 
L  K  S  D  D  I  S  H  I  D  V 
930  940  950 
AAA  AAA  GTA  T~TC~A  AAATTTCTAG  ATCA 
K  K  V  OCM 
Figure  5.  The complete annotated nucleotide sequence ofseh, upstream 
DNA and the deduced amino acid sequence of SEH. Numbers above the 
sequences refer to the nucleotide positions. The potential ribosome binding 
site (RBS) is identified at nucleotides 195-200. NH2-terminal amino acid 
sequences identical  to those of the native  protein are underlined twice. 
The proposed signal sequence processing  site is underlined once.  These 
sequence data are available from EMBL/GenBank/DDBJ under accession 
number Ul1702. 
Figure  6.  Analysis of SEH ex- 
pression in a T7 promoter system. 
SEH  preparations separated by 
SDS-PAGE were  either  stained 
with Coomassie  blue (lanes a, c, 
and e) or Western  blotted with an- 
tibody specific for wild-type SEH 
(lanes/~ d, and  f). (Lanes  a and b) 
Lysates ofE. coli strain  BL-21(DE3) 
carrying pET-17b alone; (lanes c 
and d) lysates orE. coli strain BL- 
21(DE3)  carrying pET-17b with 
a seh insert. (Lanes e and.D rSEH 
purified from a lysate of E.  coli 
strain BL-21(DE3) carrying pET- 
17b with a seh  insert. 
congestion, marked hyperemia,  and mild muhifocal fibrinoid 
degeneration of small vessel walls.  Perivascular hemorrhage, 
especially  in the adrenal gland, lungs, meninges,  and cardiac 
papillary  muscles, was also noticed (data not shown).  Mul- 
tifocal coalescing edema or atelectasis  and leukocyte seques- 
tration were observed in the lung,  interstitial  nephritis and 
tubular degeneration  and regeneration was seen in the kidney, 
and centrilobular vacuolation was visualized in liver  tissue. 
These  histopathological  features  are consistent  with  those 
found in  septic  shock  (31). 
Enhancement of Toxicity with LPS.  Whereas  the amount 
of SEH alone required to induce a TSS-like  disease in rabbits 
was quite high (see Table 1), numerous reports (for a review 
see  reference  30)  indicated  that  staphylococcal  toxins  like 
TSST-1 markedly enhanced LPS-induced toxic shock and death 
in rabbits.  Accordingly,  when injection with SEH was fol- 
lowed 4 h later by i.v. administration of LPS (5/~g/kg),  the 
dose  of SEH  needed  to  induce  toxic shock  and  death was 
markedly reduced (Table 1).  LPS alone at 5/~g/kg  did not 
result in any observable  symptoms in the rabbits.  When the 
injection of a mixture of SEH and anti-SEH rabbit IgG was 
followed by LPS injection,  the capacity of LPS  to enhance 
the activity  of SEH  was blocked.  In contrast,  two rabbits 
receiving  the mixture  of SEH plus  normal rabbit  IgG and 
LPS succumbed to lethal shock within 48 h (Table 1). These 
observations  indicate  that  a  relatively  low  dose  of LPS  is 
sufficient to increase  the activity of SEH leading  to death. 
Toxicity of the rSEH in Rabbits.  To determine if rSEH re- 
tained the toxic characteristics of the native molecule, purified 
rSEH was injected into rabbits. As shown in Table 2, purified 
....  ....  ..... 
E  T I  L  K  F  F  T  SEA  S  E  K  S  El  N  E  K  R  K  QGT  G  L  K  QI  Y  Y  E  KA  KT  K  E  H  O  QF  L  QH  K  Q 
SEE  S  E  '  N  ....  Q  .........  E  K  A[~-] .........  ~  ......  DG 
SED  S  V  E  K  K  S  S  T  N  M  K  H  S  Y  A  D  K  NI~II  I~G  ELE~K  S  T  G  O  Q  F  L  NT  LL~JL  Y  KKF  F  T 
SEDSEH  G  D  $  G~R  ~']KL  I  IDLIL  L~i  T A ~]L ~N~IIA  QJH IF  KIS ,K  V  JV ~$  F Y ~']K  ~-~lyjp  R  N  CLCJY  .....  G  ~'~f  S E ~L  ~T~p  ....  E  ~A 
SEA  H  S  WY  L  D  s  K  I  v  D  G  L  Y  Y  G  Q  AGGT  P  KT  A  M  V  H  D  N  NR  T 
SEE  H  P  WY  L  D  S  K  A  G  L  Y  Y  G  Q  AGGT  P  K  T  A  M  V  H  ON  N  R  T 
N  F  E  I  N  FF-]N  S  K  E  M  N  D  I  Y  S  I  G  E  I  D  R  T  A  T  V  H  G  N  K 
K  N  V  T  L  I  K  I  K  -  S  O  R  V~-]G "[HTV~']V~'  ~T  E~--  ~  -  '  ,  S  EiT~$  SEH  -  -  " 
SEA  E  K  K  V  P  I  ~NILIWILIO  GIKIQIN  T  V  PILIE  T  V  K  T  N  K  K  N  V  T  V  P  Q  A  R  Y  Q  s  N  L  N  S  O  V  F  G  K  VQ 
SEE  E  K  K  V  P  I  ~.~L N'  DNL~G  K TI~  E  ..........  []  ..................... 
SEO  e  R  K  KI~JP  I  L  I  V  V  SI~-ID  K  V  Q  K  K  N  VT  VIQ  E  L  OIAQA  RY  Q  K  D  L  [~L  YL~N  N  O  T  L  G  G  K~--IQ 
SEH  RK~MHT  sK~-]P  E  P  R  D  Y ~F  ~1S  V  NY  L  F  GA  QY~L~  QY  8  N  ........  T  L  L  R ~E  ~K~D  D  i  S  ~i  N  ~R  ,  N  E  N  Y  8  ....  SEA  Y  T  T  V  Y  I_  P  D  F  A Q  Q  T L  L R  R  N  E  N  R  H  S  SE  GS  SEE  Y 
SED  R  S  SO  GSK'~/  Y  L  F  V  D  F  P  E  K  Q  L  R II~_JS{D  N  K  T  LJS  T  E  H  L  Y  S 
Figure  7.  Comparison  of  the 
primary  amino  acid  sequence  of 
SEH and staphylococcal enterotox- 
ins SEA, SEE, and SED. The align- 
ment was created using the Pileup 
program (GCG). Residues that are 
identical with SEH are boxed. 
1680  New Staphylococcal Exotoxin Table  1.  Biological  Effects of the Purified Wild-type SEll on Rabbits  Table  2.  Biological Effects of the Purified Recombinant 
SEH on Rabbits 
Number of Rabbits 
SEH*  LPS*  Fevers  Hyperemia  Diarrhea  Dead 
,g/ g  ,g/kg 
40-8011  0  3/3  3/3  2/3  0/3 
150  0  3/3  3/3  3/3  2/3 
40-8011  5  3/3  3/3  2/3  3/3 
150  5  2/2  2/2  1/2  2/2 
50+ 
NRIgG I  5  2/2  2/2  2/2  2/2 
50+ 
anti-SEH  I  5  0/3**  0/3  0/3  0/3 
0  5  0/2  0/2  0/2  0/2 
* Rabbits were injected intravenously  with SEH at doses ranging from 
40 to 150/zg/kg body weight. 
* In some experiments,  endotoxin (LPS) was given intravenously at a 
dose of 5 /zg/kg body weight 4 h after injections of SEH. 
S Temperatures were determined within 4 h after SEH administration. 
II Each of three animals was injected with either 40, 60,  or 80 ttg/kg 
SEH. 
￿82  Either normal rabbit IgG (NR IgG) or anti-SEH IgG was incubated 
with SEH at a 1.5:1 molar ratio at 37~  for 2 h prior to injection of 
rabbits. 
** Temperature elevation was observed in all three rabbits injected but 
the mean value was <I~ 
rSEH  induced a  TSS-like illness in rabbits when delivered 
intravenously. Like the native SEH,  LPS also enhanced the 
activity of SEH. Toxicity of rSEH was blocked by antibody 
specific for  SEH  but not by normal rabbit  antiserum. 
Number of Rabbits 
rSEH*  LPS#  Fevers  Hyperemia  Diarrhea  Dead 
 g/kg   g/kg 
50  0  2/2  2/2  0/2  0/2 
50  5  2/2  2/2  0/2  2/2 
50 + 
NRIgG II  5  1/1  1/1  0/1  1/1 
50+ 
anti-SEH  II  5  0/11  1/1  0/1  0/1 
0  5  ND  0/2  0/2  0/2 
* Rabbits were injected intravenously  with rSEH at a dose of 50 #g/kg 
body weight. 
In some experiments,  endotoxin (LPS) was given intravenously at a 
dose of 5 #g/kg body weight 4 h after injections of SEH. 
S Temperatures  were determined within 4 h after SEH administration. 
II Either normal rabbit IgG (NR IgG) or anti-SEH IgG was incubated 
with recombinant SEH at  a 1.5:1  molar  ratio  at 37~  for 2 h before 
injection of rabbits. 
Temperature  elevation was observed but the mean value was <I~ 
Discussion 
It is now clear that staphylococcal infections can cause TSS 
in a clinical setting in which women, children, and men are 
equally involved. The proportion of nonmenstrual to men- 
strual cases, however, is increasing. Mortality with nonmen- 
strually related TSS is approximately three times higher than 
menstrually related cases  (31).  The increased mortality has 
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Figure  8.  Pyrogenic  effects  of SEH  in rabbits.  Mean 
changes in rectal temperatures among three groups of rabbits 
injected with different amounts of SEH. Group 1: each of 
three rabbits receiving either 40, 60, or 80 #g/kg toxin (I~). 
Group 2: each of three rabbits  receiving 150 #g/kg toxin 
(0). Group 3: each of three rabbits receiving a mixture of 
50 #g/kg toxin and anti-SEH IgG (ll). Two of the group 
2 rabbits died, one before 24 h, and the other between 24 
and 48 h, after i.v. injection  of SEH. The means and standard 
errors of deviation for each group are indicated at each time 
point. 
1681  Pen et al. been attributed to either the production of TSST-1 or other 
toxins or to delayed diagnosis (31). Observations that staph- 
ylococcal strains isolated from nonmenstrual  TSS often do 
not secrete or even contain the gene for TSST-1 (4) prompted 
searches for other putative toxins. Controversial results, how- 
ever, have been reported. Scott et al. (32), for example, noted 
that  a TSS-like syndrome in rabbits was associated with  a 
toxin called TSST-2 from staphylococcal strain D4508,  the 
same nonmenstrual  TSS clinical  isolate used in our studies. 
McCollister et al. (4) demonstrated that enterotoxin A is the 
major TSS-associated  toxin produced by the D4508 strain and 
that  TSST-2  was not a required  factor,  Our earlier report 
suggesting a new exotoxin from D4508 capable of causing 
a TSS-like syndrome in rabbits, raised questions as to the true 
nature of this toxin (4,  12). The present work was therefore 
undertaken  in  an  attempt  to resolve this  issue. 
By using a multistep procedure including anion exchange 
and  molecular  sieve chromatography  on  FPLC,  SEH was 
purified to homogeneity.  Laser  desorption  mass spectrom- 
etry analysis  of the purified SEH revealed a monomer with 
a molecular mass of 25.145 kD. Isoelectric focusing revealed 
that this protein has a relatively acidic pI of 5.65. These bio- 
chemical properties clearly distinguish SEH from other known 
staphylococcal exotoxins (1). Immunoblotting analyses revealed 
that the antibody specific for SEH reacted only with its cor- 
responding antigen whereas SEH did exhibit binding to mAbs 
specific for SEE and SEE), indicating that SEH contains unique 
as well as common antigenic epitopes shared by some other 
enterotoxins  (Fig.  2). 
By cloning  and  sequencing  the genetic determinant  en- 
coding SEH and by comparing the deduced amino acid se- 
quence with that in the translated GenBank, SEH was shown 
to have significant similarity with staphylococcal enterotoxin 
SEA-E and was more closely related to the SEA, SED, and 
SEE group ofenterotoxins. We thus believe that SEH might 
be a new member of the enterotoxin  gene family. 
SEH also shares many biological activities with the other 
known staphylococcal exotoxins. When administered intra- 
venously into rabbits, highly purified native as well as rSEH 
induced an acute clinical  illness characterized by high fever, 
diarrhea,  and histopathological  changes in multiorgan systems. 
These symptoms reflected the pyrogenic and toxic properties 
of SEH toxin, many of which are salient biological features 
of the staphylococcal family of enterotoxins (30). The histo- 
pathologic  changes  are  consistent  with  TSS  observed  in 
humans and are similar to those seen in animal studies using 
TSST-1  (33).  Since infection  of patients  with both gram- 
positive and gram-negative bacteria commonly occurs, and 
since endotoxemia has been seen in some patients with TSS 
(31), we evaluated the effects of SEH on enhancing the sus- 
ceptibility of rabbits  to lethal endotoxic shock in a syner- 
gistic manner.  As noted in Tables  1 and 2,  the result was 
quite striking and the amount of SEH toxin required to in- 
duce lethal toxic shock in the presence of LPS was markedly 
diminished when compared to administration of toxin alone. 
Whereas  the close correlation between the introduction 
of a TSS-like syndrome in rabbit with SEH did suggest the 
possibility of a cause-and-effect relation,  the mechanism by 
which the  toxicity occurs is not clear.  Preliminary  experi- 
ments (30, 34, 35) indicate that SEH stimulates the prolifer- 
ation  of human  peripheral  mononuclear  cells  and  highly 
purified T cells in a manner similar to that observed for en- 
terotoxins  and  TSST-1,  suggesting  that  SEH,  like  other 
staphylococcal enterotoxins, might also be a superantigen (data 
not shown).  Comparison of the SEH amino acid sequence 
with other enterotoxins  revealed that SEH contains many iden- 
tical and chemically conserved amino acid residues (Fig.  7). 
The availability of the recombinant seh clone will enable 
us to construct  isogeneic mutants  that  are deficient in the 
production of this toxin to examine its role in the pathogen- 
esis of the disease (36), which might have value for the early 
diagnosis and management of human TSS in which SEH plays 
a role. In addition,  the ability to completely block the local- 
ized effects of SEH with anti-SEH antibody may provide a 
new therapeutic method for blocking some of the effects of 
the  toxin in  a clinical  setting. 
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